Drug Shortage Report for ATRIANCE
| Report ID | 56126 |
| Drug Identification Number | 02299925 |
| Brand name | ATRIANCE |
| Common or Proper name | ATRIANCE INJ 5MG/ML 50ML X 6 |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | NELARABINE |
| Strength(s) | 5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 50ML X 6 |
| ATC code | L01BB |
| ATC description | ANTIMETABOLITES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2018-08-31 |
| Actual start date | |
| Estimated end date | 2018-09-04 |
| Actual end date | 2018-08-28 |
| Shortage status | Avoided shortage |
| Updated date | 2018-08-28 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4600 RUE ARMAND-FRAPPIER SAINT-HUBERT, QUEBEC CANADA J3Z 1G5 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2018-08-28 | French | Compare |
| v7 | 2018-08-28 | English | Compare |
| v6 | 2018-08-28 | English | Compare |
| v5 | 2018-08-16 | French | Compare |
| v4 | 2018-08-16 | English | Compare |
| v3 | 2018-08-16 | English | Compare |
| v2 | 2018-07-20 | French | Compare |
| v1 | 2018-07-20 | English | Compare |
Showing 1 to 8 of 8